8.6 C
New York
Monday, August 2, 2021
Home Health & Fitness Health Canada authorizes drug remdesivir for severe COVID-19 cases

Health Canada authorizes drug remdesivir for severe COVID-19 cases


Health Canada has authorized with conditions the drug remdesivir for patients with severe COVID-19, though Canada’s top doctor says the supply is limited.

The drug — which will go by the brand name Veklury — is manufactured by Gilead Sciences Canada.

On Tuesday, Health Canada announced the drug is now authorized for use in adults and adolescents aged 12 years and older with a body weight of at least 40 kilograms. 

The company did not seek permission to use the drug to treat pregnant women or children under 12.

In April, a study run by the U.S. National Institutes of Health tested remdesivir versus usual care in 1,063 hospitalized coronavirus patients around the world. It found that the drug reduced the time it takes patients to recover by 31 per cent  — 11 days on average versus 15 days for those just given usual care.

But Dr. Theresa Tam, chief public health officer of Canada, warned that “the supply with this company is very low globally.”

WATCH | U.S. buys global supply of remdesivir:

The U.S. has bought the global supply of remdesivir, an antiviral drug that has been found to help certain patients recover more quickly from COVID-19. 4:20

Remdesivir is administered intravenously and used only in health-care facilities where patients can be closely monitored.

“It’s not something people can go out and access by themselves,” Tam said Tuesday during a press conference.

Because the drug has been given an expedited review, the manufacturer will have to ensure the continued safety, efficacy and quality of the drug, a statement by Health Canada said

Some Canadians have already been treated with drug

Remdesivir has also been granted emergency or conditional authorization in the U.S., Europe, Australia, Singapore and Japan.

In Canada, a small number of patients have been or are being treated with the drug under the Special Access Program.

Asked about reports the drug will be expensive, Tam said that may be the case, but the price will be subject to “appropriate reviews.”

“I am aware some of these drugs are going to cost a fair amount of money,” Tam said. “We have to look at access, as well as what’s a reasonable price.”



Source link

Today news
Today News 1 runs four of the western GTA’s most influential media websites, offering news, food, lifestyle and entertainment coverage for millions to the Golden Horseshoe and GTA regions. The independently-run, online news source was founded in 2019 and specializes in everything from breaking news to food and restaurant, arts and entertainment and lifestyle coverage.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisment -

Most Popular

Rapper DaBaby cut from Lollapalooza music festival over recent homophobic comments

Rapper DaBaby was cut Sunday from Lollapalooza's closing lineup following crude and homophobic remarks he made last week at a Miami-area music festival....

Oilpatch revival underway with robust profits so far this year

After racking up debt in 2020, the Canadian oilpatch is enjoying a rebound so far this year as major oil producers are gushing...

Business travel isn’t expected to return to pre-pandemic levels anytime soon

Kacey Siskind recently took her first business trip to the U.S. since the pandemic began.  The vice-president of business development at Honk Mobile, a...

Pop star Kris Wu detained by Beijing police on suspicion of sexual assault

Chinese-Canadian pop star Kris Wu has been detained by Beijing police on suspicion of rape, police announced Saturday, following an accusation the former...

Recent Comments